Skip to main content
. 2022 Oct 26;11:47. doi: 10.1186/s40035-022-00321-1

Fig. 5.

Fig. 5

Existing compounds that have been investigated thus far in animal studies and clinical trials (circle) or have FDA-approved formulations (rectangle) by mechanism of impact on OPC proliferation, OL differentiation/maturation, and/or myelination